iDNA Genomics Public Ltd

Regulatory Filings • Mar 10, 2022

10th March 2022

Mr. Nikos Tripatsas Acting General Manager Cyprus Stock Exchange Nicosia

ANNOUNCEMENT

Topic: Restrictive measures of the Council of the European Union and other sanctions against Russia in response to the crisis in Ukraine / War in Ukraine – Economic consequences / risks and uncertainties

iDNA Genomics Public Ltd (the "Company") would like to inform the investing public that based on the developments to date in relation to the war in Ukraine, the restrictive measures of the European Council and other sanctions taken against Russia, the Company's operations have not been affected and no major impact is expected on its business and its financial results.

However, the Company is unable to state with certainty how and to what extent this crisis might affect its operations and financial results, as the war is evolving, new developments are taking place daily and new restrictions/ sanctions are imposed.

The Company further notes that any prolonged or extended conflict in the region, will most likely have an adverse effect on its activities, as it would expect the demand for its 'Wellness' products to drop, as consumers tighten their budgets and focus on their primary needs. Further, as oil prices rise, the Company would expect an increase in expenses to the degree that any such increase would affect all organizations and markets in the region.

The Company is monitoring the situation in order to take any necessary actions to minimize, as much as possible, any potential impact from the crisis caused by the war in Ukraine, on its business, operation and its results; should there be one.

Kind regards,

Fotis Sakellarides Executive Director